SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
TPG Private Equity Opportunities entered into a $125 million revolving credit agreement on August 26, 2026, creating a new direct financial obligation with specified terms, interest rates, covenants, and maturity date.
View raw filing on EDGAR →The Manager declared a daily distribution of $0.0000684930 per share for the September 2026 Distribution Period, equating to approximately 0.25% on an annualized basis. This is a routine but material dividend declaration to shareholders, clearly falling within the dividend_distribution category. The disclosure specifies the distribution amount, record dates, and payment schedule.
View raw filing on EDGAR →NACCO disclosed results of operations and financial condition through an investor presentation dated August 2026, highlighting financial performance, business platforms, EBITDA metrics, balance sheet strength (liquidity of $114.6M, debt of $120.1M), recurring EBITDA expectations ($50M from current businesses plus $11M from 2025 projects), and dividend increases.
View raw filing on EDGAR →The Board appointed Byron Pollan to the newly created position of Senior Vice President and Deputy Chief Financial Officer effective September 1, 2026, with a planned succession to Chief Financial Officer in mid-2027 upon Ron Copher's retirement.
View raw filing on EDGAR →Incyte has entered into a pricing agreement with CMS affecting access to Jakafi and Jakafi XR through state Medicaid programs and providing relief from future CMS pricing mandates (GUARD and GLOBE models). While the company states no material impact on 2026 guidance or future outlook, the agreement represents a material operational and strategic development affecting drug pricing, market access, and regulatory exposure for a major product line. This is a significant business arrangement that does not fit neatly into other categories but is clearly operational in nature.
View raw filing on EDGAR →Angie J. Klein tendered her resignation from The Buckle's Board of Directors, effective August 30, 2026, after serving since December 2019. The filing explicitly states this is a departure due to obligations related to her new professional role, with no disagreement with the Company. This is a clear board director departure, which is material to investors as it affects board composition and governance.
View raw filing on EDGAR →Suzano has entered into an agreement to acquire a 10% equity stake in Imetame Logística Porto S.A., a greenfield port project under construction in Aracruz, Brazil. The transaction involves contribution of Suzano-owned land and represents a material acquisition activity. Although Suzano characterizes the investment as "not material" to its capital structure, the strategic nature of the transaction—involving a major infrastructure project with partnerships including Hapag-Lloyd's terminal division and expected operations beginning in 2027–2028—constitutes a material acquisition or investment that would affect a reasonable investor's assessment of the company's strategic direction and capital allocation.
View raw filing on EDGAR →Martin Franc has been appointed as Senior Managing Director and Head of Asia Pacific, succeeding Andrew Lo who will retire effective March 31, 2027, after 32 years with Invesco. This represents material succession planning for a key executive position overseeing a significant regional business.
View raw filing on EDGAR →EFCAR transferred sub-prime automobile loan receivables to a trust structure and the trust issued approximately $1.06 billion in aggregate principal amount of asset-backed notes across eight classes (A-1 through N). This constitutes creation of a new direct financial obligation through debt issuance. While the transaction involves securitization and multiple agreements, the core material event is the issuance of the asset-backed notes, which is the primary financial obligation created on the Closing Date of August 31, 2026.
View raw filing on EDGAR →The filing discloses equity compensation grants approved by the Compensation Committee on August 13, 2026: (1) up to 125,000 performance stock units to Bradley S. Vizi (Executive Chairman and President) with vesting tied to EBITDA and individual performance goals, and (2) restricted stock units to Kevin D. Miller (CFO) and Michael Saks (Division President) vesting over five years. These are compensatory arrangements for named executives under Item 5.02(e), distinct from executive departures or appointments.
View raw filing on EDGAR →The disclosure describes a permanent closure of the Monterrey Facility with planned workforce reduction, estimated one-time cash expenditures of $20–$25 million (including ~$11.5 million in severance costs), and phased wind-down through Q2 2027. This is a material operational restructuring with associated exit costs disclosed under Item 2.05, the standard Item for workforce reductions and disposal activities.
View raw filing on EDGAR →IRSA has signed a barter agreement for a 2,095 sqm lot with 7,483 sqm total saleable area as part of the "Ramblas del Plata" real estate development project, valued at approximately USD 6.7 million. This is a material operational/strategic transaction involving a significant real estate acquisition and development activity, but does not fit the specific categories of M&A (no change of control), debt issuance, or other defined event types. The transaction is material to investors as it represents a substantial capital commitment and project expansion for this real estate company.
View raw filing on EDGAR →The disclosure reports a favorable Federal Circuit Court of Appeals decision in Exelixis, Inc. v. MSN Laboratories Private Limited affirming that three Exelixis patents (11,091,439, 11,091,440, and 11,098,015) are not invalid, which establishes a January 15, 2030 earliest effective date for FDA approval of MSN's generic ANDA. This patent litigation outcome materially affects the timing and competitive landscape for a generic competitor's market entry and is therefore a material litigation event. The filing also references ongoing separate litigation involving U.S. Patent No. 12,128,039 with trial scheduled for November 2026, further underscoring the litigation context.
View raw filing on EDGAR →Microvast received written notice from Nasdaq on August 26, 2026, that the average closing bid price of its common stock fell below the $1 minimum required under Nasdaq Rule 5450(a)(1). The company has 180 days to cure the deficiency; failure to do so would trigger a delisting notice and potential removal from Nasdaq. This is a classic delisting-risk disclosure under Item 3.01(a) of Form 8-K, materially affecting investor assessment of the registrant's continued public listing status.
View raw filing on EDGAR →The media release announces the appointment of three non-executive directors—Stephan B. Tanda, Denise C. Johnson, and Robert Schuchna—to the combined company Board upon completion of the pending AkzoNobel-Axalta merger. The disclosure explicitly states these individuals "have agreed to serve as non-executive Directors of the combined company" and details their qualifications and roles. This is a governance event involving executive/director appointments material to the merged entity's leadership structure.
View raw filing on EDGAR →Vesta announced a credit rating upgrade from 'BBB-' to 'BBB' with stable outlook from Fitch Ratings. While this is a positive financial development reflecting the company's "strong financial profile, solid profitability, prudent capital structure and adequate liquidity," it is not a discrete operational, financial, or legal event but rather an external validation of the company's creditworthiness. The upgrade materially affects investor perception and capital access, but does not fit neatly into the event taxonomy (not earnings, M&A, debt issuance, impairment, or other specific categories). Classified as governance_other because credit rating actions, while financial in nature, are governance-adjacent signals of institutional confidence and are best captured in this residual category when they do not trigger a specific event type.
View raw filing on EDGAR →FactSet entered into Amendment No. 1 to its existing credit agreement on August 28, 2026, extending the maturity dates of its $375 million term loan facility to August 28, 2029 and its revolving facility to August 28, 2031, while increasing revolving commitments from $1 billion to $1.5 billion and removing certain credit spread adjustments and amortization requirements. This material restructuring modifies the company's direct financial obligations and capital structure.
View raw filing on EDGAR →BXP completed the issuance and sale of $700.0 million aggregate principal amount of 6.050% Senior Notes due 2036 on August 31, 2026. This is a material creation of a direct financial obligation. The filing explicitly describes the underwriting agreement, the terms of the notes, and the intended use of proceeds to refinance maturing 2026 Notes, which is a classic debt issuance disclosure under Item 2.03 (though filed under Item 8.01).
View raw filing on EDGAR →This exhibit announces positive initial assay results from a sampling program on stockpiles under a profit-share agreement with Red Eye Resources, indicating gold and silver grades (weighted average 2.83 g Au and 753.41 g Ag) that will inform processing decisions at Nicola's Merritt Mill. The disclosure is operational—it reports on exploration/sampling results and next steps (laboratory simulations)—rather than a discrete event like M&A, financing, or executive action. It is material because it provides technical data that could affect investor assessment of the company's near-term mill utilization and project economics.
View raw filing on EDGAR →The exhibit discloses that Zentek's common shares are ceasing to trade on the Nasdaq Capital Market and transitioning to OTC Markets quotation effective September 2, 2026. While framed as a correction to a prior release, the substance is a material delisting from Nasdaq to OTC tier status, which materially affects trading liquidity and investor access. The company notes it has applied for OTCQX Best Market admission but until approved will trade on an initial OTC tier, and acknowledges that "trading in the common shares over the counter in the United States may be less liquid than trading on a national securities exchange."
View raw filing on EDGAR →Ralph Max Hofmeier resigned effective immediately from his positions as Chairman and director on August 26, 2026, citing disagreement with the CEO over operations, policies, and practices, and alleging unlawful activities and fiduciary breaches. While the filing also discloses subsequent director appointments and board restructuring, the principal disclosed action centers on Hofmeier's departure from a senior leadership position. The resignation of a Chairman is material to investors assessing governance and leadership stability.
View raw filing on EDGAR →Utah Medical Products' wholly-owned subsidiary Femcare Ltd has purchased all common shares of Orion Medical Supplies Ltd, a UK-based medical device assembler and distributor. The acquisition is expected to add approximately $6 million to UTMD's consolidated annual sales and was completed for £3.6 million in cash. This constitutes a material acquisition requiring disclosure under Item 1.01 of Form 8-K, disclosed here under Item 7.01 (Regulation FD Disclosure) via press release.
View raw filing on EDGAR →The filing discloses the appointment of Quentin Blackford, an experienced healthcare executive (currently CEO of iRhythm Technologies), to Align Technology's Board of Directors effective August 27, 2026. While the section also mentions Andrea L. Saia's resignation, the principal disclosed action centers on the appointment of a new director. Blackford's appointment is material as it represents a change in board composition and governance at a large-cap medical device company, and his background in healthcare and digital innovation is relevant to investor assessment of board quality and strategic direction.
View raw filing on EDGAR →TELA Bio announced a Board-approved workforce reduction plan reducing headcount by approximately 20% (from 201 to 160 employees) as part of a $17 million annual cost reduction initiative, with expected one-time restructuring charges of $1.5 million in severance and employee-related costs to be incurred in Q3 2026.
View raw filing on EDGAR →Roberto Cuca stepped down as Chief Financial Officer, Chief Operating Officer, and Corporate Secretary effective August 31, 2026, treated as a termination without cause. Heather Getz was appointed as principal financial officer to succeed him.
View raw filing on EDGAR →This exhibit is a press release announcing So-Young's unaudited second quarter 2026 financial results, dated August 31, 2026. It discloses total revenues of RMB505.2 million (up 33.4% YoY), aesthetic treatment services revenues of RMB331.4 million (up 129.5% YoY), and net loss of RMB22.7 million (improved from RMB36.0 million loss in Q2 2025). The document includes detailed financial statements, operational metrics, management commentary, and forward guidance for Q3 2026, all characteristic of a quarterly earnings release.
View raw filing on EDGAR →FirstCash entered into the Tenth Amendment to its credit agreement on August 27, 2026, which increased the total lender commitment from $700 million to $1.055 billion, extended the maturity from August 2029 to August 2031, and amended financial covenants. While technically an amendment to an existing facility rather than a new debt issuance, this represents a material creation of new direct financial obligations—the company increased its available borrowing capacity by $355 million and extended its debt maturity profile. The filing itself cross-references Item 2.03 (Creation of a Direct Financial Obligation), confirming the registrant's own characterization of this as a material financial obligation event.
View raw filing on EDGAR →The disclosure announces both an increase in the Company's annual cash dividend from $2.10 to $2.20 per share and a declaration of a third quarter 2026 dividend of $0.55 per share payable September 30, 2026. This is a clear dividend distribution event with a material capital allocation decision (the seventh dividend increase in six years), which would affect a reasonable investor's assessment of the company's capital allocation policy and shareholder returns.
View raw filing on EDGAR →This exhibit is a press release announcing MINISO Group's unaudited financial results for the six months and quarter ended June 30, 2026 ("26H1" and "26Q2"). It discloses revenue of RMB11,498.9 million (up 22.4% YoY), profit for the period of RMB956.6 million (up 5.6% YoY), diluted EPS of RMB3.16 (up 8.2% YoY), and detailed operational metrics including store expansion and segment performance. This is a discrete earnings announcement, not a periodic financial report filing itself, and would materially affect investor assessment of the registrant's financial performance and trajectory.
View raw filing on EDGAR →Brookfield Renewable Partners is soliciting shareholder and unitholder votes on a proposed plan of arrangement to simplify its corporate structure by consolidating BEP, BEPC, and BEP Inc. into a single publicly traded entity. The special meeting is scheduled for October 14, 2026, with voting materials including a proxy statement and management information circular describing the arrangement and dissent rights.
View raw filing on EDGAR →Brookfield Infrastructure Corp is soliciting shareholder and unitholder votes on a proposed plan of arrangement to simplify the corporate structure through an exchange of securities, with a special meeting scheduled for October 14, 2026. The transaction involves Brookfield Infrastructure Partners L.P., Brookfield Infrastructure Corporation, and Brookfield Infrastructure Partners Inc., and may result in a change to the listing status of BIPC.
View raw filing on EDGAR →This exhibit announces a fundamental business transformation of Amber International Holding Ltd from "Amber Premium" to "AMBR," a rebranding and strategic pivot to an agentic AI company focused on building specialized AI agents for finance, enterprise, and growth. The company is launching flagship products (Ambre for personal finance and MIA for marketing). This is a material operational and strategic business event—a significant pivot in business model and market positioning—that does not fit the specific named event types but clearly falls within the operational domain as a major strategic transformation and product launch.
View raw filing on EDGAR →Brookfield Private Equity Fund LP sold approximately $3,074,000 of unregistered limited partnership units (Class S and Class I) on August 1, 2026, pursuant to a continuous private offering exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →This exhibit discloses a material financial restructuring combining warrant exercise proceeds (€2.5M), debt drawdowns (€1.2M), and debt-to-equity conversion (€1.4M) that strengthens cash position to €3.0M and extends runway into Q1 2027. While the disclosure includes operational updates (Phase 2 obesity study, Hong Kong JV), the primary substance is financial restructuring and capital management—a material financial event that does not fit the specific categories of debt_issuance (no new debt created), dilutive_issuance (warrant exercise is not an unregistered sale), or dividend_distribution. The 30% debt reduction and cash runway extension would affect a reasonable investor's assessment of the registrant's financial viability.
View raw filing on EDGAR →The Board declared a distribution of $0.29 per share to common shareholders, payable September 15, 2026. This is a direct capital distribution to shareholders and constitutes a dividend or distribution event material to investors assessing shareholder returns and capital allocation.
View raw filing on EDGAR →Agnico Eagle's subsidiary Avenir acquired 666,667 units of Canada Nickel Company Inc. for C$1,000,000.50 in a private placement, increasing Agnico Eagle's beneficial ownership from 8.91% to 8.68% on a non-diluted basis and from 11.78% to 11.52% on a partially-diluted basis. This represents a material investment activity in a strategic position, disclosed under the framework of an investor rights agreement that grants Agnico Eagle participation rights and board nomination rights in Canada Nickel.
View raw filing on EDGAR →Camping World entered into an Amended and Restated Credit Agreement on August 25, 2026, creating a new $175.0 million senior secured mortgage loan facility with M&T Bank. The facility includes $132.8 million funded at closing and $42.2 million in delayed draw commitments, extending the maturity from October 2027 to August 2031.
View raw filing on EDGAR →Cohen & Company's operating subsidiary issued an Amended and Restated Senior Promissory Note in the principal amount of $5,000,000 to JKD Capital Partners I LTD (owned by a board member and his spouse) on August 31, 2026, bearing interest at 10% per annum (11% upon default) with quarterly interest payments and senior status relative to other indebtedness.
View raw filing on EDGAR →IX Acquisition Corp. entered into SAFE Agreements (Simple Agreements for Future Equity) with investors for an aggregate of $13,000,000 in private placements, convertible into approximately 1,130,435 shares of Parent Common Stock at $11.50 per share plus an additional 1,062,609 incentive shares held in escrow. This represents a dilutive equity issuance that will significantly increase share count upon conversion at the merger closing, materially affecting existing shareholders.
View raw filing on EDGAR →Pacific Coast Oil Trust issued a press release on August 31, 2026, announcing its monthly net profits interest calculations for June 2026, which is the Trust's primary operational and financial metric. The disclosure includes detailed financial results (operating loss of ~$73,000 on Developed Properties, sales volumes, average prices per Boe, and cumulative net profits deficits), though notably announcing zero cash distribution to unitholders. This is a routine monthly financial disclosure typical of royalty trusts, filed under Item 2.02 (Results of Operations and Financial Condition), and constitutes an earnings-type release even though it reports a loss and no distribution.
View raw filing on EDGAR →Victory Capital entered into a definitive Merger Agreement on August 25, 2026 to acquire First Eagle through a two-step merger structure, with consideration comprising cash, newly issued common stock (4.9% of post-closing shares), and convertible preferred stock. The transaction is subject to HSR approval and customary closing conditions, and will be financed through substantial debt facilities ($3.5B term loan, $200M revolver, and $950M bridge facility).
View raw filing on EDGAR →Dr. Allen R. Jones, Jr. resigned as a director of Primis Financial Corp. effective August 31, 2026, and also resigned from the Enterprise Risk Committee. The disclosure explicitly states the resignation was not due to any dispute or disagreement. This is a clear director departure, which is material to investors as it affects board composition and governance structure (reducing the board from eleven to ten directors).
View raw filing on EDGAR →Tidewater completed its acquisition of Wilson Sons Ultratug (WSUT) for USD $500 million aggregate purchase price (USD $283.1 million cash paid and USD $229.3 million debt assumed) on a debt-free, cash-free basis, effective August 31, 2026. The acquisition adds a 22-vessel PSV fleet that expands Tidewater's leading global market position in offshore support vessels.
View raw filing on EDGAR →Digi International entered into an amended and restated $350 million senior secured revolving credit facility on August 27, 2026, expanding from a prior $250 million facility with improved pricing terms (SOFR margins of 125-262.5 bps vs. prior 135-310 bps) and extended maturity to August 27, 2031, providing total potential borrowing capacity of up to $480 million.
View raw filing on EDGAR →The Company disclosed termination of an equity distribution agreement with Jefferies LLC and entry into a new equity distribution agreement with Huntington Securities, Inc., both relating to an at-the-market (ATM) offering program under which the Company may offer and sell up to $500 million in common stock and preferred stock. This represents a material capital-raising mechanism that could result in significant dilution to existing shareholders, and the replacement of one sales agent with another signals ongoing reliance on this dilutive financing vehicle.
View raw filing on EDGAR →Gerdau S.A. and affiliated companies entered into a new Senior Unsecured Global Working Capital Credit Agreement on August 31, 2026, increasing the credit facility from US$875 million to US$1,125 million (a 29% increase). This represents creation of a new direct financial obligation and is a material capital event for the registrant, administered by Crédit Agricole and syndicated among nine major banks with a five-year term maturing in August 2031.
View raw filing on EDGAR →This press release announces IperionX's receipt of a second U.S. Army task order (Task Order 2) under its existing SBIR Phase III contract, with US$11.5 million currently obligated and up to US$25.4 million potential value. The disclosure describes a material operational and strategic milestone—expansion of the company's titanium powder-to-part manufacturing capacity at its Virginia facility, including continuous HSPT™ furnace development, in-house fastener finishing equipment, and industrial-scale dehydrogenation furnaces. While this is a government contract award (operational/strategic), it does not fit the specific categories of M&A activity, debt issuance, equity dilution, or other named event types; it is a material contract/partnership milestone that would affect a reasonable investor's assessment of the company's growth trajectory and defense-sector positioning.
View raw filing on EDGAR →KKR posted a presentation on its website titled "Sale of USI Insurance Services to Aon plc," disclosing a material disposition of a business unit. While the Item 7.01 disclosure is minimal and non-binding, the sale of a portfolio company (USI Insurance Services) to a third party (Aon plc) constitutes a material acquisition/disposition event that would affect investor assessment of KKR's portfolio and capital deployment. The presentation itself likely contains substantive transaction details, making this a material M&A activity disclosure.
View raw filing on EDGAR →Prairie Operating Co. entered into a Letter Agreement with Hudson Bay PH XIX LLC amending existing securities arrangements, extending the Anniversary Warrant Issuance Date from August 31, 2026 to December 1, 2026 and adding a contingent Second Penny Warrant for 3,000,000 shares at $0.01 exercise price. This contractual amendment modifies warrant terms and financial obligations under a prior Securities Purchase Agreement.
View raw filing on EDGAR →BridgeBio announced a voluntary agreement with the U.S. government to expand Medicaid access to its marketed medicine (Attruby) and lower drug costs, with the company expecting to avoid future pricing mandates. This is a material strategic and regulatory agreement affecting the company's commercial operations and pricing framework, but it does not fit neatly into the specific event categories (not M&A, not a restatement, not a covenant breach, not litigation). The agreement is operational and regulatory in nature, affecting market access and pricing policy going forward.
View raw filing on EDGAR →